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Tumour necrosis factors (TNFs) are produced in animals in response to bacterial endotoxins. They were 
first recognized as factors that cause haemorrhagic necrosis of some transplantable murine tumours, an ef- 
fect (together with earlier clinical observations) which raised the possibility that they might have useful an- 
titumour actions in humans. It is now recognized that TNFs have a wide range of actions on many cell types, 
and that in vivo they have a number of toxic side effects in addition to their antitumour actions: these limit 
their clinical usefulness. Two TNFs have been well-characterized and cloned. TNF-cu (probably identical to 
cachectin, produced primarily by macrophages) and TNF-fl (also known as lymphotoxin, produced primari- 
ly by lymphocytes). 
This book presents the proceedings of a Ciba Foundation Symposium, held in January 1987, on the TNFs 
and related factors. Progress in the field has been very rapid in the past few years and it is perhaps not sur- 
prising therefore that both the individual articles and the extensive transcripts of discussions concentrate 
on details of recent research. One or two chapters giving an overview of the field would have been useful 
for readers not immediately and directly involved in this specialist field. Chapters within the book present 
accounts of the production of the TNFs, their antitumour and cytotoxic actions, other physiological actions 
(including production of cachexia, antiparasitic and antiviral actions, and interactions with other lym- 
phokines such as interleukin-1 and y-interferon), mechanism of action and clinical aspects. The structure 
of TNFs, structure-function studies and the nature of the genes for these polypeptides are referred to in 
several chapters, but the book would have benefitted from one or two early chapters covering these topics 
in more depth. Although TNF-a and -fl produced by recombinant DNA methodology are now available it 
is clear that the protein chemistry of these polypeptides is not completely understood, and their relationship 
to other factors is confused. Such confusion is apparent from contributions to this book, and clearly limits 
understanding and progress to some extent, for example the relationship between TNF-a and cachectin, 
where identity is considered to be fully established by some authors (e.g. Tracey et al., pp.88-102) but 
uncertain by others (e.g. Aggarwal et al., pp.39-47). It is disappointing that there is rather little considera- 
tion of such matters in the extensive discussions recorded in the book. 
As with other volumes in the Ciba Foundation Symposia Series, the book is well produced and reasonably 
priced. For those involved already in the TNF field it provides a valuable in-depth account of most aspects 
of the area. Those more peripherally interested in TNF, who want an overview of the field, will be able 
to get it here but will have to work hard to do so. 
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